Inventory increased 15.6%
Inventory changed +15.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed +15.6% from the comparable as-filed period.
Net income changed +285.0% from the comparable as-filed period.
Operating income changed +154.6% from the comparable as-filed period.
Operating margin changed +1423 basis points from the comparable as-filed period.
Selling, general & administrative changed -26.4% from the comparable as-filed period.
Gross profit changed +6.2% from the comparable as-filed period.
Research & development changed -7.6% from the comparable as-filed period.
Revenue changed +5.8% from the comparable as-filed period.
Gross margin changed +15 basis points from the comparable as-filed period.
Cash & equivalents changed +2.8% from the comparable as-filed period.
Stock-based compensation changed -3.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.